A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate how the body handles and metabolizes (PK) the various doses of
the drug Tolvaptan, and what the effect (PD) of the various doses of Tolvaptan are on the
content of "salt" in blood and urine
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.